Original paper
Adjuvant synergy: The effects of nasal coadministration of adjuvants
Abstract
Modern peptide and protein subunit vaccines suffer from poor immunogenicity and require the use of adjuvants. However, none of the currently licensed adjuvants can elicit cell-mediated immunity or are suitable for mucosal immunization. In this study we explored the immunological effect of nasal co-administration of adjuvants with distinct functions: cholera toxin subunit B, a potent mucosal adjuvant that induces strong humoral responses, muramy...
Paper Details
Title
Adjuvant synergy: The effects of nasal coadministration of adjuvants
Published Date
Nov 2, 2004
Journal
Volume
82
Issue
6
Pages
628 - 637